Gapping up
In reaction to strong earnings/guidance:
- CASY +9.4%
M&A news:
- BKS +2.9% (reports of competing Readerlink bid)
Select metals/mining stocks trading higher after China Iron Ore futures jump 6% on speculation that demand will continue to exceed production over the coming months:
- MT +6.3%, FCX +4.1%, X +3.7%, BHP +3.2%, RIO +2.7%, XME +2.6%
Other news:
- PRVB +20.4% (files for 5.5 mln share common stock offering; Amgen has agreed to purchase $20 mln of common stock in a private placement)
- AVGO +3.5% (Broadcom subsidiaries entered into statement of work with Apple [AAPL] providing for a supply arrangement for two years of new programs )
- VCYT +3.2% (announces new publication of data demonstrating real-world performance of the Afirma Genomic Sequencing Classifier in thyroid cancer diagnosis)
- TLRY +2% (Valens expands size and scope of agreement with Tilray)
- ZEAL +1.8% (presents elaborated results from pivotal Phase 3 study of dasiglucagon as treatment for severe hypoglycemia)
Analyst comments:
- NBEV +5.2% (initiated with Buy at Compass Point)
- LYFT +3.9% (upgraded to Positive from Neutral at Susquehanna)
- JBLU +3.6% (upgraded to Buy from Neutral at Citigroup)
- FORM +2.9% (initiated with a Buy at Needham)
- SESN +2.6% (upgraded to Buy at H.C. Wainwright)
- FB +1.5% (upgraded to Buy from Neutral at MoffettNathanson)
- VER +1.4% (upgraded to Buy from Underperform at BofA/Merrill)
- ZTS +1.2% (initiated with an Overweight at Barclays)
- PSA +0.8% (upgraded to Sector Weight from Underweight at KeyBanc Capital Markets)